University of Arizona researchers achieved nearly 90% accuracy in pancreatic cancer phenotyping using label-free optical microscopy with deep learning AI.
Key Details
- 1Label-free optical microscopy paired with deep neural networks identified tissue phenotypes at over 89% accuracy in pancreatic cancer samples.
- 2Spatial transcriptomics served as the 'ground truth' for phenotypic classification.
- 3Traditional image analysis could not match the performance of AI methods, pointing to AI's necessity in extracting meaningful features from label-free images.
- 4This approach bypasses expensive and time-intensive molecular/genetic sequencing currently used in precision medicine.
- 5The work demonstrates a significant step toward more accessible and rapid phenotyping for cancer care.
Why It Matters
This study advances the use of imaging AI in precision medicine by offering a faster, less costly method for cancer phenotyping. It highlights the potential for optical imaging and AI to broaden access to personalized care by reducing dependence on resource-heavy molecular diagnostics.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.